NASEM re­leas­es re­port on med­ical sup­ply-chain re­silien­cy

4 years ago
Manufacturing

Af­ter 25 years, Hov­ione's CEO will step down; Helsinn gains in­fi­gra­tinib li­cense from Bridge­Bio 

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: 9 part­ners to help Bio­vac's man­u­fac­tur­ing ex­pan­sion; Af­ter pro­duc­tion pledges, ...

4 years ago
Manufacturing

Catal­ent ex­pands in­hala­tion ef­forts in col­lab­o­ra­tion with Texas-based phar­ma

4 years ago
Pharma
Manufacturing

With new Alzheimer's pre­ven­tion tri­al, Roche and Genen­tech may put amy­loid hy­poth­e­sis to ul­ti­mate test

4 years ago
R&D

Af­ter buy­ing out Flex­ion for $450M, Paci­ra qui­et­ly lays off 110 of its em­ploy­ees

4 years ago
People
R&D

Egg al­ler­gy tri­als halt­ed by Aim­mune; At­las clos­es its 13th fund for $450M

4 years ago
News Briefing

FDA push­es back a re­view date for TG's 'U2' com­bo as the biotech steels it­self for up­com­ing ad­comm

4 years ago
FDA+

Bio­gen be­gins lay­ing off staff as it con­tin­ues to push its new Alzheimer's drug

4 years ago
Pharma

Long­time Hutchmed CEO Hogg de­parts, hand­ing over the reins amid US ex­pan­sion plans

4 years ago
People

WHO OKs mol­nupi­ravir as treat­ment for Covid-19, af­ter new da­ta from In­dia

4 years ago
Coronavirus

Rus­si­a's war in Ukraine is now de­lay­ing da­ta read­outs, as Tri­ci­da says its sec­ond-chance tri­al needs more time

4 years ago
R&D

Full da­ta for Sanofi and As­traZeneca's new RSV an­ti­body raise ques­tions about just how wide­ly it will be used

4 years ago
R&D

Two Re­pub­li­can sen­a­tors call on CMS to not re­strict cov­er­age to amy­loid-tar­get­ed Alzheimer's drugs

4 years ago
FDA+

Sanofi inks an al­liance pact with chron­ic dis­ease-fo­cused dig­i­tal ther­a­peu­tics play­er

4 years ago
Deals
Pharma

Ogilvy Health hires strat­e­gy chief with DTC and con­sumer ex­pe­ri­ence — now one step clos­er to full ex­ec team

4 years ago
Pharma
Marketing

FDA be­gins court-man­dat­ed re­lease of thou­sands of pages on Pfiz­er's Covid-19 vac­cine re­view

4 years ago
FDA+
Coronavirus

Ster­ling builds up its API ca­pac­i­ty with big buy of No­var­tis cam­pus in Ire­land

4 years ago
Pharma
Manufacturing

NIH foun­da­tion taps top Mer­ck ex­ec — and oft-cit­ed woman of the year — Julie Ger­berd­ing to steer pub­lic-pri­vate ...

4 years ago
People
Pharma

Push­ing back against Eli Lil­ly mo­tion, fed­er­al judge sends years-long whistle­blow­er case to tri­al

4 years ago
Pharma
Law

Roche steps up with a free sup­ply of an­tibi­otics for Ukraine as drug do­na­tions be­gin to flow

4 years ago
Pharma

Is­raeli phar­ma touts PhI­II for pre­ma­ture in­fant in­testi­nal mal­a­dy; No­var­tis backs a British biotech's Se­ries B

4 years ago
News Briefing

Up­dat­ed: Weak­er Omi­cron vari­ant is great news for the world, but bad news for Covid-re­lat­ed clin­i­cal tri­als

4 years ago
R&D
Coronavirus

Months af­ter IPO, Ital­ian vial com­pa­ny lands BAR­DA in­vest­ment as gov­ern­ment looks to shore up pan­dem­ic pre­pared­ness

4 years ago
Manufacturing
First page Previous page 573574575576577578579 Next page Last page
A service from the Financial Times